These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8395592

  • 21. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C, Bergeron C, Lane D, Garon G, Piché A.
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [Abstract] [Full Text] [Related]

  • 22. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD.
    J Neurosci Res; 1994 Nov 01; 39(4):506-11. PubMed ID: 7884826
    [Abstract] [Full Text] [Related]

  • 23. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
    Paquin A, Jaalouk DE, Galipeau J.
    Hum Gene Ther; 2001 Jan 01; 12(1):13-23. PubMed ID: 11177538
    [Abstract] [Full Text] [Related]

  • 24. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.
    Hlavatý J, Hlubinová K, Altanerová V, Líska J, Altaner C.
    Neoplasma; 1997 Jan 01; 44(6):342-7. PubMed ID: 9605005
    [Abstract] [Full Text] [Related]

  • 25. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.
    Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA.
    Cancer Res; 1994 Nov 15; 54(22):5745-51. PubMed ID: 7954393
    [Abstract] [Full Text] [Related]

  • 26. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA, Roper MD, Kleinschmidt-DeMasters BK, Banuelos SJ, Smiley WR, Robbins JM, Burrows FJ.
    Cancer Gene Ther; 1997 Nov 15; 4(2):118-28. PubMed ID: 9080121
    [Abstract] [Full Text] [Related]

  • 27. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D, Hardin J, Ray J, Gage FH.
    J Neurosurg; 1993 Nov 15; 79(5):729-35. PubMed ID: 8410252
    [Abstract] [Full Text] [Related]

  • 28. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO.
    Cancer J Sci Am; 1998 Nov 15; 4(6):364-9. PubMed ID: 9853135
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
    Izquierdo M, Martín V, de Felipe P, Izquierdo JM, Pérez-Higueras A, Cortés ML, Paz JF, Isla A, Blázquez MG.
    Gene Ther; 1996 Jun 15; 3(6):491-5. PubMed ID: 8789798
    [Abstract] [Full Text] [Related]

  • 31. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
    Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM, Kaiser LR.
    Hum Gene Ther; 1998 May 01; 9(7):1083-92. PubMed ID: 9607419
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.
    Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748
    [Abstract] [Full Text] [Related]

  • 37. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.
    Vile RG, Nelson JA, Castleden S, Chong H, Hart IR.
    Cancer Res; 1994 Dec 01; 54(23):6228-34. PubMed ID: 7954471
    [Abstract] [Full Text] [Related]

  • 38. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors.
    von Eckardstein KL, Patt S, Zhu J, Zhang L, Cervós-Navarro J, Reszka R.
    Histol Histopathol; 2001 Jul 01; 16(3):735-44. PubMed ID: 11510963
    [Abstract] [Full Text] [Related]

  • 39. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.
    Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM.
    Science; 1992 Jun 12; 256(5063):1550-2. PubMed ID: 1317968
    [Abstract] [Full Text] [Related]

  • 40. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1996 Oct 20; 7(16):1989-94. PubMed ID: 8930659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.